Showing results (1671-1680 of 1,697) with videos related to
Sort By:
Pageof 170
Cancer Communications (London, England)|March 20, 2019
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancerFeng-Hua Wang, Lin Shen, Jin Li, et al.Vaccine|November 4, 2024
Comparison of the safety and persistence of immunogenicity of bivalent HPV16/18 vaccine in healthy 9-14-year-old and 18-26-year-old Chinese females: A randomized, double-blind, non-inferiority clinical trialJuan Li, Li-Wei Shi, Ke Li, et al.Frontiers in Immunology|July 15, 2021
Single-Dose Immunization With a Chimpanzee Adenovirus-Based Vaccine Induces Sustained and Protective Immunity Against SARS-CoV-2 InfectionMingxi Li, Jingao Guo, Shuaiyao Lu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, et al.BMC Urology|March 29, 2018
Triptorelin relieves lower urinary tract symptoms in Chinese advanced prostate cancer patients: a multicenter, non-interventional, prospective studyLe-Ye He, Ming Zhang, Zhi-Wen Chen, et al.Journal of Interventional Medicine|July 6, 2023
Expert consensus on the clinical application of totally implantable venous access devices in the upper arm (2022 Edition)Xiaoxia Qiu, Guangxin Jin, Xuebin Zhang, et al.International Journal of Clinical and Experimental Pathology|January 23, 2020
High infiltration of CD68-tumor associated macrophages, predict poor prognosis in Kazakh esophageal cancer patientsXue Li Wang, Kai Liu, Ji Hong Liu, et al.Chinese Medical Journal|January 4, 2007
Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, ChinaJian-qing Xu, Jian-jun Wang, Li-feng Han, et al.Journal of Medicinal Chemistry|December 19, 2022
Discovery of a Series of Potent, Selective, and Orally Bioavailable Nucleoside Inhibitors of CD73 That Demonstrates <i>In Vivo</i> Antitumor ActivityJim Li, Lijing Chen, Roland J Billedeau, et al.Human Vaccines & Immunotherapeutics|October 26, 2023
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trialGuang-Wei Feng, Zhong-Fang Wang, Peng He, et al.Pageof 170